Skip to main content
Nature Communications logoLink to Nature Communications
. 2024 Sep 17;15:8143. doi: 10.1038/s41467-024-52439-7

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production

James R Tribble 1,#, Melissa Jöe 1,#, Carmine Varricchio 2, Amin Otmani 1, Alessio Canovai 1,3, Baninia Habchi 4,5,6, Evangelia Daskalakis 4,5, Romanas Chaleckis 4,5,7, Andrea Loreto 8,9, Jonathan Gilley 8, Craig E Wheelock 4,5, Gauti Jóhannesson 10,11, Raymond C B Wong 12,13, Michael P Coleman 8, Andrea Brancale 2,14, Pete A Williams 1,
PMCID: PMC11408734  PMID: 39289370

Correction to: Nature Communications 10.1038/s41467-024-50354-5, published online 24 July 2024

In this article Figure 1 was an older version, which does not match the figure legend and duplicates panels from Figure 2. The updated and correct Figure 1 is below.graphic file with name 41467_2024_52439_Figa_HTML.jpg

Data has not changed, and no text was amended. The original article has been corrected.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES